
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.3B | $1.7B | $2.5B | $2.9B | $3B | |
Revenue Growth (YoY) | -66.44% | 26.59% | 50.22% | 14.61% | 4.19% | |
Cost of Revenues | $1.7B | $1.7B | $2.1B | $2.2B | $2.1B | |
Gross Profit | -$401.6M | -$55.4M | $400.1M | $681.5M | $908.8M | |
Gross Profit Margin | -30.11% | -3.28% | 15.77% | 23.44% | 30% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $586.4M | $610.1M | $661.2M | $634.4M | $622.7M | |
Other Inc / (Exp) | -$91.1M | -$15.1M | $132.9M | -$92.8M | -$57M | |
Operating Expenses | $586.4M | $610.1M | $661.2M | $634.4M | $622.7M | |
Operating Income | -$988M | -$665.5M | -$261.1M | $47.1M | $286.2M | |
Net Interest Expenses | $225.8M | $257.8M | $295.2M | $447.9M | $509.6M | |
EBT. Incl. Unusual Items | -$1.3B | -$938.4M | -$423.4M | -$493.5M | -$280.5M | |
Earnings of Discontinued Ops. | $2.8M | -$2.5M | -$679K | $308K | -- | |
Income Tax Expense | -$21M | -$14.6M | $8.7M | $34.7M | -$1.8M | |
Net Income to Company | -$1.3B | -$926.3M | -$432.8M | -$527.9M | -$278.7M | |
Minority Interest in Earnings | -$1.2M | -$2.2M | -$2.7M | $332K | -$76K | |
Net Income to Common Excl Extra Items | -$1.3B | -$928.5M | -$435.4M | -$527.6M | -$278.8M | |
Basic EPS (Cont. Ops) | -$4.45 | -$2.96 | -$1.40 | -$1.56 | -$0.73 | |
Diluted EPS (Cont. Ops) | -$4.45 | -$2.96 | -$1.40 | -$1.56 | -$0.73 | |
Weighted Average Basic Share | $289.9M | $320.9M | $326.7M | $346.6M | $383.7M | |
Weighted Average Diluted Share | $289.9M | $320.9M | $326.7M | $346.6M | $383.7M | |
EBITDA | -$715.4M | -$418.4M | $56.4M | $103M | $358.7M | |
EBIT | -$1.1B | -$680.6M | -$128.2M | -$45.6M | $229.2M | |
Revenue (Reported) | $1.3B | $1.7B | $2.5B | $2.9B | $3B | |
Operating Income (Reported) | -$988M | -$665.5M | -$261.1M | $47.1M | $286.2M | |
Operating Income (Adjusted) | -$1.1B | -$680.6M | -$128.2M | -$45.6M | $229.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $327.5M | $584.9M | $742.7M | $782.9M | $776.6M | |
Revenue Growth (YoY) | -50.3% | 78.61% | 26.98% | 5.41% | -0.8% | |
Cost of Revenues | $399.4M | $496.8M | $578.5M | $543.4M | $529.9M | |
Gross Profit | -$71.9M | $88.1M | $164.2M | $239.5M | $246.7M | |
Gross Profit Margin | -21.97% | 15.07% | 22.11% | 30.59% | 31.76% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $130.6M | $167.7M | $164.4M | $141.4M | $143.3M | |
Other Inc / (Exp) | $10.7M | $187.5M | $2.8M | -$41.5M | $4.4M | |
Operating Expenses | $130.6M | $167.7M | $164.4M | $141.4M | $143.3M | |
Operating Income | -$202.6M | -$79.5M | -$213K | $98.1M | $103.4M | |
Net Interest Expenses | $64.1M | $61.1M | $99.8M | $124.7M | $129.4M | |
EBT. Incl. Unusual Items | -$255.9M | $46.9M | -$97.2M | -$68.2M | -$21.5M | |
Earnings of Discontinued Ops. | -$263K | $134K | -$403K | -- | -- | |
Income Tax Expense | $4M | -$596K | $2.2M | $2.9M | -$57.1M | |
Net Income to Company | -$260.2M | $47.7M | -$99.8M | -$71.1M | $35.5M | |
Minority Interest in Earnings | -$484K | -$272K | $835K | -$378K | -$213K | |
Net Income to Common Excl Extra Items | -$260.7M | $47.4M | -$98.9M | -$71.5M | $35.3M | |
Basic EPS (Cont. Ops) | -$0.84 | $0.13 | -$0.32 | -$0.19 | $0.09 | |
Diluted EPS (Cont. Ops) | -$0.84 | $0.12 | -$0.32 | -$0.19 | $0.09 | |
Weighted Average Basic Share | $317.6M | $323.7M | $328.9M | $379.8M | $386.3M | |
Weighted Average Diluted Share | $317.6M | $409.4M | $328.9M | $379.8M | $455.3M | |
EBITDA | -$118.6M | $158.1M | $42.9M | $90.7M | $137.6M | |
EBIT | -$191.8M | $108M | $2.6M | $56.6M | $107.8M | |
Revenue (Reported) | $327.5M | $584.9M | $742.7M | $782.9M | $776.6M | |
Operating Income (Reported) | -$202.6M | -$79.5M | -$213K | $98.1M | $103.4M | |
Operating Income (Adjusted) | -$191.8M | $108M | $2.6M | $56.6M | $107.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1B | $1.9B | $2.7B | $2.9B | $3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.5B | $1.8B | $2.2B | $2.2B | $2.1B | |
Gross Profit | -$525.8M | $104.7M | $476.2M | $756.8M | $916M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $513.4M | $647.1M | $657.9M | $611.4M | $624.5M | |
Other Inc / (Exp) | -$32.2M | $161.7M | -$51.9M | -$137.1M | -$11M | |
Operating Expenses | $513.4M | $647.1M | $657.9M | $611.4M | $624.5M | |
Operating Income | -$1B | -$542.5M | -$181.7M | $145.4M | $291.5M | |
Net Interest Expenses | $252.4M | $254.8M | $334M | $472.8M | $514.2M | |
EBT. Incl. Unusual Items | -$1.3B | -$635.5M | -$567.5M | -$464.5M | -$233.8M | |
Earnings of Discontinued Ops. | $4.7M | -$2.1M | -$1.2M | $711K | -- | |
Income Tax Expense | $10.2M | -$19.2M | $11.5M | $35.5M | -$61.8M | |
Net Income to Company | -$1.3B | -$618.4M | -$580.2M | -$499.3M | -$172M | |
Minority Interest in Earnings | -$901K | -$2M | -$1.6M | -$881K | $89K | |
Net Income to Common Excl Extra Items | -$1.3B | -$620.4M | -$581.8M | -$500.2M | -$171.9M | |
Basic EPS (Cont. Ops) | -$4.48 | -$2.01 | -$1.84 | -$1.42 | -$0.44 | |
Diluted EPS (Cont. Ops) | -$4.48 | -$2.02 | -$1.84 | -$1.42 | -$0.44 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$730.3M | -$141.7M | -$58.7M | $150.8M | $405.6M | |
EBIT | -$1.1B | -$380.7M | -$233.6M | $8.3M | $280.4M | |
Revenue (Reported) | $1B | $1.9B | $2.7B | $2.9B | $3B | |
Operating Income (Reported) | -$1B | -$542.5M | -$181.7M | $145.4M | $291.5M | |
Operating Income (Adjusted) | -$1.1B | -$380.7M | -$233.6M | $8.3M | $280.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $327.5M | $584.9M | $742.7M | $782.9M | $776.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $399.4M | $496.8M | $578.5M | $543.4M | $529.9M | |
Gross Profit | -$71.9M | $88.1M | $164.2M | $239.5M | $246.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $130.6M | $167.7M | $164.4M | $141.4M | $143.3M | |
Other Inc / (Exp) | $10.7M | $187.5M | $2.8M | -$41.5M | $4.4M | |
Operating Expenses | $130.6M | $167.7M | $164.4M | $141.4M | $143.3M | |
Operating Income | -$202.6M | -$79.5M | -$213K | $98.1M | $103.4M | |
Net Interest Expenses | $64.1M | $61.1M | $99.8M | $124.7M | $129.4M | |
EBT. Incl. Unusual Items | -$255.9M | $46.9M | -$97.2M | -$68.2M | -$21.5M | |
Earnings of Discontinued Ops. | -$263K | $134K | -$403K | -- | -- | |
Income Tax Expense | $4M | -$596K | $2.2M | $2.9M | -$57.1M | |
Net Income to Company | -$260.2M | $47.7M | -$99.8M | -$71.1M | $35.5M | |
Minority Interest in Earnings | -$484K | -$272K | $835K | -$378K | -$213K | |
Net Income to Common Excl Extra Items | -$260.7M | $47.4M | -$98.9M | -$71.5M | $35.3M | |
Basic EPS (Cont. Ops) | -$0.84 | $0.13 | -$0.32 | -$0.19 | $0.09 | |
Diluted EPS (Cont. Ops) | -$0.84 | $0.12 | -$0.32 | -$0.19 | $0.09 | |
Weighted Average Basic Share | $317.6M | $323.7M | $328.9M | $379.8M | $386.3M | |
Weighted Average Diluted Share | $317.6M | $409.4M | $328.9M | $379.8M | $455.3M | |
EBITDA | -$118.6M | $158.1M | $42.9M | $90.7M | $137.6M | |
EBIT | -$191.8M | $108M | $2.6M | $56.6M | $107.8M | |
Revenue (Reported) | $327.5M | $584.9M | $742.7M | $782.9M | $776.6M | |
Operating Income (Reported) | -$202.6M | -$79.5M | -$213K | $98.1M | $103.4M | |
Operating Income (Adjusted) | -$191.8M | $108M | $2.6M | $56.6M | $107.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.5B | $978.4M | $794.9M | $648.2M | $724.5M | |
Short Term Investments | -- | -- | $54.3M | $52M | $555K | |
Accounts Receivable, Net | $255.5M | $259.9M | $353.6M | $343.4M | $340M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $77.2M | $71.2M | $94.3M | $42.9M | $38.8M | |
Other Current Assets | $25M | $17.3M | $16.4M | $21.1M | $13.7M | |
Total Current Assets | $1.9B | $1.4B | $1.4B | $1.2B | $1.2B | |
Property Plant And Equipment | $488.6M | $349.4M | $314.7M | $303.6M | $315.7M | |
Long-Term Investments | $24.3M | $22.7M | $22.4M | $22.3M | $22.5M | |
Goodwill | $2.6B | $2.5B | $2.5B | $2.6B | $2.6B | |
Other Intangibles | $511.4M | $440.7M | $410.3M | $376.1M | $337.9M | |
Other Long-Term Assets | $107.1M | $278.7M | $50.3M | $56.1M | $60M | |
Total Assets | $6.1B | $5.3B | $5B | $4.7B | $4.6B | |
Accounts Payable | $115.2M | $122.9M | $171.1M | $231.8M | $263.7M | |
Accrued Expenses | $294.3M | $326.2M | $432.5M | $435M | $460.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | $21.1M | -- | -- | -- | |
Total Current Liabilities | $621.9M | $716.5M | $815.6M | $914.7M | $1.1B | |
Long-Term Debt | $4.7B | $4.7B | $4.7B | $4.8B | $4.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.8B | $5.8B | $5.8B | $6B | $6.2B | |
Common Stock | $3.4M | $3.5M | $3.6M | $4.1M | $4.1M | |
Other Common Equity Adj | -$136M | -$80.3M | -$65.7M | -$73.9M | -$73.7M | |
Common Equity | $278.1M | -$508.9M | -$884.4M | -$1.4B | -$1.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $7M | $9.2M | $11.5M | $27M | $27.3M | |
Total Equity | $285.2M | -$499.7M | -$872.8M | -$1.4B | -$1.6B | |
Total Liabilities and Equity | $6.1B | $5.3B | $5B | $4.7B | $4.6B | |
Cash and Short Terms | $1.5B | $978.4M | $849.2M | $700.2M | $725M | |
Total Debt | $4.7B | $4.8B | $4.7B | $4.8B | $5.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.3B | $1.2B | $817.1M | $629.1M | $651.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $294M | $333.6M | $414.5M | $411.4M | $397.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $154M | $137.4M | $189.8M | $165.3M | $154.8M | |
Total Current Assets | $1.7B | $1.7B | $1.4B | $1.2B | $1.2B | |
Property Plant And Equipment | $323.4M | $238.6M | $230.8M | $242.9M | $251.1M | |
Long-Term Investments | $23.9M | $23M | $22.5M | $23.2M | $22.5M | |
Goodwill | $2.6B | $2.5B | $2.5B | $2.6B | $2.6B | |
Other Intangibles | $494M | $424.9M | $400.7M | $366.3M | $329.4M | |
Other Long-Term Assets | $599.5M | $447.4M | $348.1M | $313M | $294.7M | |
Total Assets | $5.8B | $5.3B | $5B | $4.7B | $4.7B | |
Accounts Payable | $104.2M | $155.8M | $192.3M | $249.8M | $258.8M | |
Accrued Expenses | $306.7M | $370.1M | $491.3M | $458.3M | $490.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $642M | $694.5M | $863.7M | $892.7M | $1.1B | |
Long-Term Debt | $4.7B | $4.7B | $4.8B | $5B | $4.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.8B | $5.8B | $6B | $6.2B | $6.2B | |
Common Stock | $3.4M | $3.5M | $19.2M | $4.1M | $4.2M | |
Other Common Equity Adj | -$135.7M | -$77.8M | -$64.5M | -$69.7M | -$75.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $7.5M | $9.3M | $11M | $27.7M | $27.5M | |
Total Equity | $31.7M | -$437.7M | -$949M | -$1.4B | -$1.5B | |
Total Liabilities and Equity | $5.8B | $5.3B | $5B | $4.7B | $4.7B | |
Cash and Short Terms | $1.3B | $1.2B | $817.1M | $629.1M | $651.1M | |
Total Debt | $4.7B | $4.7B | $4.9B | $5B | $5.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.3B | -$926.3M | -$432.8M | -$527.9M | -$278.7M | |
Depreciation & Amoritzation | $363.7M | $262.2M | $184.6M | $148.7M | $129.5M | |
Stock-Based Compensation | $69.9M | $120.9M | $82.9M | $52M | $54.6M | |
Change in Accounts Receivable | $205M | -$17.9M | -$122.3M | -$1.5M | $13.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$773.2M | -$418.2M | -$279.7M | $55.8M | $70.6M | |
Capital Expenditures | $65.4M | $54.3M | $69.5M | $87.4M | $84.1M | |
Cash Acquisitions | -- | -- | -$68.8M | -$12M | -- | |
Cash From Investing | -$1.3M | -$29.4M | $174M | -$110M | -$29.6M | |
Dividends Paid (Ex Special Dividend) | -$44.4M | -$21.6M | -$21.4M | -$16M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $3B | $1.1B | $1.8B | $1.7B | $1.9B | |
Long-Term Debt Repaid | -$1.5B | -$1.1B | -$1.8B | -$1.7B | -$1.8B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$158.2M | -$13M | -$33.8M | -$139.4M | -$50.3M | |
Cash From Financing | $1.8B | -$50.6M | -$75.4M | -$94.2M | $39.6M | |
Beginning Cash (CF) | $436.2M | $1.5B | $999.4M | $815.9M | $669.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.1B | -$498.1M | -$181.1M | -$148.4M | $80.6M | |
Ending Cash (CF) | $1.5B | $999.4M | $815.9M | $669.2M | $745.5M | |
Levered Free Cash Flow | -$838.6M | -$472.5M | -$349.2M | -$31.6M | -$13.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$260.2M | $47.7M | -$99.8M | -$71.1M | $35.5M | |
Depreciation & Amoritzation | $73.2M | $50.1M | $40.3M | $34.2M | $29.8M | |
Stock-Based Compensation | $24.4M | $27.6M | $17M | $13.9M | $13.7M | |
Change in Accounts Receivable | -$41.1M | -$106.7M | -$73.8M | -$74.7M | -$118.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$197.7M | -$140.8M | -$72.4M | -$68.1M | -$80.6M | |
Capital Expenditures | $6.4M | $17.4M | $18.1M | $27.7M | $17.9M | |
Cash Acquisitions | $14.8M | $392.3M | -- | -- | -- | |
Cash From Investing | $8.4M | $374.9M | -$18.1M | -$27.7M | -$8.3M | |
Dividends Paid (Ex Special Dividend) | -$5.4M | -$5.3M | -$5.3M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $625M | $115M | $340.1M | $41.1M | |
Long-Term Debt Repaid | -$6.3M | -$625.3M | -$5.9M | -$211.4M | -$25.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$64K | -$9.9M | $13.4M | -$48.7M | -- | |
Cash From Financing | -$24.2M | -$25.8M | $111.9M | $77.9M | $13.2M | |
Beginning Cash (CF) | $1.5B | $999.4M | $815.9M | $669.2M | $745.5M | |
Foreign Exchange Rate Adjustment | -$1.2M | -$205K | $715K | -$1.2M | $2.3M | |
Additions / Reductions | -$213.5M | $208.3M | $21.5M | -$17.9M | -$75.6M | |
Ending Cash (CF) | $1.3B | $1.2B | $838.1M | $650.2M | $672.2M | |
Levered Free Cash Flow | -$204.1M | -$158.2M | -$90.5M | -$95.8M | -$98.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.3B | -$618.4M | -$580.2M | -$499.3M | -$172M | |
Depreciation & Amoritzation | $341.1M | $239.1M | $174.8M | $142.5M | $125.1M | |
Stock-Based Compensation | $76.8M | $124.1M | $72.3M | $48.9M | $54.3M | |
Change in Accounts Receivable | $43.2M | -$83.4M | -$89.4M | -$2.4M | -$30.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$1B | -$361.2M | -$211.3M | $60.1M | $58.1M | |
Capital Expenditures | $43.4M | $65.3M | $70.2M | $97M | $74.4M | |
Cash Acquisitions | $14.8M | $377.4M | -$461.1M | -$12M | -- | |
Cash From Investing | $40M | $337M | -$219M | -$119.5M | -$10.2M | |
Dividends Paid (Ex Special Dividend) | -$11.3M | -$21.5M | -$21.4M | -$10.7M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.6B | $1.7B | $1.3B | $2B | $1.6B | |
Long-Term Debt Repaid | -$1.5B | -$1.7B | -$1.2B | -$1.9B | -$1.7B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$84.1M | -$22.9M | -$10.5M | -$201.6M | -- | |
Cash From Financing | $1.6B | -$52.2M | $62.4M | -$128.3M | -$25.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $605M | -$76.4M | -$367.9M | -$187.7M | $22.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$1.1B | -$426.5M | -$281.5M | -$36.9M | -$16.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$260.2M | $47.7M | -$99.8M | -$71.1M | $35.5M | |
Depreciation & Amoritzation | $73.2M | $50.1M | $40.3M | $34.2M | $29.8M | |
Stock-Based Compensation | $24.4M | $27.6M | $17M | $13.9M | $13.7M | |
Change in Accounts Receivable | -$41.1M | -$106.7M | -$73.8M | -$74.7M | -$118.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$197.7M | -$140.8M | -$72.4M | -$68.1M | -$80.6M | |
Capital Expenditures | $6.4M | $17.4M | $18.1M | $27.7M | $17.9M | |
Cash Acquisitions | $14.8M | $392.3M | -- | -- | -- | |
Cash From Investing | $8.4M | $374.9M | -$18.1M | -$27.7M | -$8.3M | |
Dividends Paid (Ex Special Dividend) | -$5.4M | -$5.3M | -$5.3M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $625M | $115M | $340.1M | $41.1M | |
Long-Term Debt Repaid | -$6.3M | -$625.3M | -$5.9M | -$211.4M | -$25.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$64K | -$9.9M | $13.4M | -$48.7M | -- | |
Cash From Financing | -$24.2M | -$25.8M | $111.9M | $77.9M | $13.2M | |
Beginning Cash (CF) | $1.5B | $999.4M | $815.9M | $669.2M | $745.5M | |
Foreign Exchange Rate Adjustment | -$1.2M | -$205K | $715K | -$1.2M | $2.3M | |
Additions / Reductions | -$213.5M | $208.3M | $21.5M | -$17.9M | -$75.6M | |
Ending Cash (CF) | $1.3B | $1.2B | $838.1M | $650.2M | $672.2M | |
Levered Free Cash Flow | -$204.1M | -$158.2M | -$90.5M | -$95.8M | -$98.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.